Perioperative Sleep Quality and Postoperative Pain Outcomes
Launched by GRANT HEYDINGER · Sep 20, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • able to read, understand, and speak English
- • are undergoing ACL repair or reconstruction
- • have availability of a mobile device/computer to receive text messages
- Exclusion Criteria:
- • \< 10 or \> 18 years of age
- • have a history of sleep-disordered breathing including sleep apnea
- • have a history of chronic pain or current opioid use
- • have a history of developmental delay that would preclude study participation
About Grant Heydinger
Grant Heydinger is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and cutting-edge methodologies, Heydinger leads initiatives that bridge the gap between scientific discovery and clinical application. By fostering collaborations with leading research institutions and healthcare professionals, he aims to ensure the highest standards of quality and integrity in clinical trials. Grant Heydinger's expertise in regulatory compliance and patient engagement underpins his mission to facilitate the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported